Treatment satisfaction and quality of life using an early insulinization strategy with insulin glargine compared to an adjusted oral therapy in the management of Type 2 diabetes: The Canadian INSIGHT Study-Reference-Cited by-同舟云学术

Treatment satisfaction and quality of life using an early insulinization strategy with insulin glargine compared to an adjusted oral therapy in the management of Type 2 diabetes: The Canadian INSIGHT Study

Published:2007-11 Issue:2 Volume:78 Page:254-258
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Houlden Robyn,Ross Stuart,Harris Stewart,Yale Jean-Francois,Sauriol Luc,Gerstein Hertzel C.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference12 articles.

1. Patient-assessed health outcome measures for diabetes: a structured review;Garratt;Diab. Med.,2002

2. Standards of medical care in diabetes;American Diabetes and Association;Diab. Care,2004

3. Canadian Diabetes Association 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.;Can. J. Diab.,2003

4. Intensive insulin therapy in Type 1 diabetes mellitus;Leahy,2002

5. Insulin glargine;Campbell;Clin. Ther.,2001

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The association between uncontrolled hyperglycemia (Type-2 Diabetes) and cardiovascular sequelae in patients with and without insulin;Saudi Pharmaceutical Journal;2024-10

2. Insulin therapy in type 2 diabetes: Insights into clinical efficacy, patient-reported outcomes, and adherence challenges;World Journal of Diabetes;2024-05-15

3. Psychosocial and Behavioural Aspects of Diabetes;Textbook of Diabetes;2024-01-12

4. Changes of health-related quality of life after initiating basal insulin treatment among people with type 2 diabetes;Medicine;2023-08-25

5. Effects of Metabolic Medicine and Metabolic Surgery on Patient-Reported Outcomes Among Patients with Type 2 Diabetes;Metabolic Syndrome and Related Disorders;2022-11-01